Conducting a comprehensive investigation into the immune cell landscape, our analysis revealed markedly elevated proportions of B cells, Macrophages, Myeloid dendritic cells, Neutrophils, T cell CD4+, and T cell CD8+ in patients with CRC compared to those in the normal control cohort (Fig 3A and 3B). The gene discussed is CD4; the disease is colorectal carcinoma.